Go to your personalised cancer information and support area
Learn more about the dashboardExisting My Macmillan user? Access your events and volunteer services.
The web Directory of Information Materials for People Affected by Cancer is regularly updated and currently has details of over 1,900 booklets, leaflets, books and audiovisual materials for people affected by cancer. Most have been published in the last five years but we have included some older ones that are still useful.
Myeloma UK
This treatment guide has information about thalidomide, a drug used in the treatment of myeloma. It explains what it is, how it works, and how it is given, and describes the possible side-effects.
Lymphoma Action
CAR T-cell therapy, is a type of targeted treatment used for certain types of high-grade (fast-growing) lymphoma. This factsheet explains what CAR T cells are, who can have them and how they are given, the benefits, and the possible side effects.
Myeloma UK
This treatment guide has information about carfilzomib, a proteasome inhibitor used in the treatment of myeloma. It describes how carfilzomib works, how it is given and the possible side effects.
Myeloma UK
Pomalidomide, also known as Imnovid®, is an immunomodulatory drug used in the treatment of myeloma. This treatment guide describes how it works, how it is given and the possible side effects.
Roy Castle Lung Cancer Foundation
If you or someone you care for has lung cancer, and targeted therapy is a possible treatment, then it’s almost certain that you will have a lot of questions. We have produced this booklet in partnership with lung cancer experts and people affected by lung cancer to help you make positive, informed choices about your care and treatment.
Myeloma UK
Bortezomib, also known as Velcade®, is a proteasome inhibitor drug used in the treatment of myeloma. This factsheet describes what it is, how it works, how it is given, and possible side-effects.
Breast Cancer Care
This booklet explains what pertuzumab is, when it’s given and its possible side effects. Pertuzumab is the generic (non-branded) name of the drug. Its current brand name is Perjeta®.
Lymphoma Action
Steroids are often part of treatment for Hodgkin and non-Hodgkin lymphoma, including cutaneous (skin) lymphoma. This factsheet explains what steroids are, when and how they might be given, possible side effects, and the precautions that people should take when they are on steroids.
Myeloma UK
Daratumumab, also known as Darzalex®, is a monoclonal antibody drug used in the treatment of myeloma. This booklet describes what it is, how it works, how it is given, and the possible side-effects.
Myeloma UK
Isatuximab is a new drug that is being investigated for the treatment of myeloma. This factsheet describes briefly what it is, how it works, how it is given, the possible benefits over existing drugs, the possible side-effects, and its availability in the UK.
Safe payments by:
We're here to provide physical, financial and emotional support. So whatever cancer throws your way, we're right there with you. Contact us
© Macmillan Cancer Support 2019 © Macmillan Cancer Support, registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Also operating in Northern Ireland. A company limited by guarantee, registered in England and Wales company number 2400969. Isle of Man company number 4694F. Registered office: 89 Albert Embankment, London SE1 7UQ. VAT no: 668265007